Use of chloroquine, hydroxychloroquine and 4 amino-quinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards HIV sensitive strains and towards HIV strains which are resistant to both nucleosidic and non-nucleosidic reverse transcriptase inhibitors and to proteases inhibitors
AssigneeValpharma S.A.
InventorsRoberto Valducci, Taziano Alighieri, Serozh Avanessian
Life of this patent
Estimating the term…
Abstract
Use of at least one 4 amino-quinolinic derivative to obtain a drug for the anti-retroviral therapy, especially in the therapy of the HIV disease-infection caused by retroviral strains, which are sensitive and/or resistant to known therapies. Said 4 amino-quinolinic derivative is chloroquine and/or hydroxychloroquine and the drug can be orally administered once or several times a day.
Claims21
1) Use of at least one 4 amino-quinolinic derivative to obtain a drug characterised in that said drug is for the anti-retroviral therapy.
9) Use of at least one 4 amino-quinolinic derivative according to one of the claims from 1 to 8 characterised in that said drug is administered once or several times a day.
20) Use of at least one 4 amino-quinolinic derivative according to each of preceding claims characterised in that the therapy is for treating HIV infection-disease.
21) Use of at least one 4 amino-quinolinic derivative according to each of preceding claims characterised in that the therapy is for treating HIV infection-disease partially or totally resistant to known therapies.
Dependencies are inferred from the claim text.